Association Between Executive Dysfunction-Related Activities of Daily Living Disability and Clinical Dementia Rating Domain Patterns in Patients With Vascular Dementia and Age-Matched Patients With Alzheimer’s Dementia

키워드

참고문헌 (47)

1. World Alzheimer report 2018: the state of the art of dementia research: new frontiers, "Alzheimer’s Disease International", Alzheimer’s Disease International, ~ (2018)
2. Suh GH, "Dementia in Korea : trend and projection", J Korean Geriatr Psychiatry, 6, pp.79~87 (2002)
3. Kelley AS, "The burden of health care costs for patients with dementia in the last 5 years of life", Ann Intern Med, 163, pp.729~736 (2015)
4. Barker WW, "Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank", Alzheimer Dis Assoc Disord, 16, pp.203~212 (2002)
5. Jorm AF, "The incidence of dementia : a meta-analysis", Neurology, 51, pp.728~733 (1998)
6. Alzheimer’s Association, "2016 Alzheimer’s disease facts and figures", Alzheimers Dement, 12, pp.459~509 (2016)
7. Geldmacher DS, "Evaluation of dementia", N Engl J Med, 335, pp.330~336 (1996)
8. Alexopoulos P, "Validation of the Addenbrooke’s cognitive examination for detecting early Alzheimer’s disease and mild vascular dementia in a German population", Dement Geriatr Cogn Disord, 22, pp.385~391 (2006)
9. Giebel CM, "Taking a positive spin : preserved initiative and performance of everyday activities across mild Alzheimer’s, vascular and mixed dementia", Int J Geriatr Psychiatry, 32, pp.959~967 (2017)
10. Rocca WA, "The prevalence of vascular dementia in Europe : facts and fragments from 1980-1990 studies", Ann Neurol, 30, pp.817~824 (1991)
11. Tierney MC, "Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia", Arch Neurol, 58, pp.1654~1659 (2001)
12. "Guidance on the use of donepezil, rivastigmine, and galantamine for the treatment of Alzheimer’s disease"[URL]
13. Román GC, "Vascular dementia : distinguishing characteristics, treatment, and prevention", J Am Geriatr Soc, 51(5 Suppl 2), pp.S296~S304 (2003)
14. Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140, pp.566~572 (1982)
15. Morris JC, "The clinical dementia rating(CDR) : current version and scoring rules", Neurology, 43, pp.2412~2414 (1993)
16. Chaves ML, "Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients", Alzheimer Dis Assoc Disord, 21, pp.210~217 (2007)
17. Fuh JL, "Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia", J Neurol Neurosurg Psychiatry, 76, pp.1337~1341 (2005)
18. Rosness TA, "The clinical dementia rating scale could be helpful in differentiating frontotemporal dementia from Alzheimer’s disease", Int J Geriatr Psychiatry, 26, pp.879~880 (2011)
19. Lee JH, "Development of the Korean version of the consortium to establish a registry for Alzheimer’s disease assessment packet(CERAD-K) : clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.P47~P53 (2002)
20. Rosen WG, "Pathological verification of ischemic score in differentiation of dementias", Ann Neurol, 7, pp.486~488 (1980)
21. Cho MJ, "Validation of geriatric depression scale, Korean version(GDS)in the assessment of DSM-III-R major depression", J Korean Neuropsychiatr Assoc, 38, pp.48~63 (1999)
22. Seo EH, "Normative study of the Stroop color and word test in an educationally diverse elderly population", Int J Geriatr Psychiatry, 23, pp.1020~1027 (2008)
23. Kim TH, "Korean version of frontal assessment battery : psychometric properties and normative data", Dement Geriatr Cogn Disord, 29, pp.363~370 (2010)
24. 김신겸, "한국 노인에서의 Executive Clock Drawing Task(CLOX) 정상규준 연구", 신경정신의학, 48(6), pp.436~445 (2009), 대한신경정신의학회
25. Gélinas I, "Development of a functional measure for persons with Alzheimer’s disease : the disability assessment for dementia", Am J Occup Ther, 53, pp.471~481 (1999)
26. Berg L, "Clinicopathologic studies in cognitively healthy aging and Alzheimer’s disease : relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype", Arch Neurol, 55, pp.326~335 (1998)
27. Morris JC, "Mild cognitive impairment represents early-stage Alzheimer disease", Arch Neurol, 58, pp.397~405 (2001)
28. Fillenbaum GG, "Estimating the validity of the clinical dementia rating scale : the CERAD experience", Aging Clin Exp Res, 8, pp.379~385 (1996)
29. Román GC, "Vascular dementia : diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop", Neurology, 43, pp.250~260 (1993)
30. McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDSADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease", Neurology, 34, pp.939~944 (1984)
31. Looi JC, "Differentiation of vascular dementia from AD on neuropsychological tests", Neurology, 53, pp.670~ (1999)
32. Román GC, "Executive control function : a rational basis for the diagnosis of vascular dementia", Alzheimer Dis Assoc Disord, 13(Suppl 3), pp.S69~S80 (1999)
33. World Alzheimer report 2015: the global impact of dementia, "Prince M", Alzheimer’s Disease International, 25~46 (2015)
34. Kim KW, "A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea", J Alzheimers Dis, 23, pp.281~291 (2011)
35. Andersen K, "Gender differences in the incidence of AD and vascular dementia : the EURODEM studies", Neurology, 53, pp.1992~ (1999)
36. Ott A, "Prevalence of Alzheimer’s disease and vascular dementia : association with education. The Rotterdam study", BMJ, 310, pp.970~973 (1995)
37. Burke WJ, "Reliability of the Washington university clinical dementia rating", Arch Neurol, 45, pp.31~32 (1988)
38. McCulla MM, "Reliability of clinical nurse specialists in the staging of dementia", Arch Neurol, 46, pp.1210~1211 (1989)
39. Morris JC, "Clinical dementia rating : a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type", Int Psychogeriatr, 9(Suppl 1), pp.173~176 (1997)
40. O’Brien JT, "Vascular cognitive impairment", Lancet Neurol, 2, pp.89~98 (2003)
41. Stebbins GT, "Gray matter atrophy in patients with ischemic stroke with cognitive impairment", Stroke, 39, pp.785~793 (2008)
42. Desmond DW, "The neuropsychology of vascular cognitive impairment : is there a specific cognitive deficit?", J Neurol Sci, 226, pp.3~7 (2004)
43. Graham NL, "Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia", J Neurol Neurosurg Psychiatry, 75, pp.61~71 (2004)
44. Kertesz A, "Neuropsychological deficits in vascular dementia vs Alzheimer’s disease. Frontal lobe deficits prominent in vascular dementia", Arch Neurol, 51, pp.1226~1231 (1994)
45. Tekin S, "Activities of daily living in Alzheimer’s disease : neuropsychiatric, cognitive, and medical illness influences", Am J Geriatr Psychiatry, 9, pp.81~86 (2001)
46. O’Bryant SE, "Executive functioning mediates the link between other neuropsychological domains and daily functioning : a project FRONTIER study", Int Psychogeriatr, 23, pp.107~113 (2011)
47. Lezak MD, "Neuropsychological assessment" (2004), Oxford University Press

관련 논문AI추천